Page last updated: 2024-08-22

vidarabine and Chronic Disease

vidarabine has been researched along with Chronic Disease in 98 studies

Research

Studies (98)

Timeframe	Studies, this research(%)	All Research%
pre-1990	33 (33.67)	18.7374
1990's	9 (9.18)	18.2507
2000's	27 (27.55)	29.6817
2010's	26 (26.53)	24.3611
2020's	3 (3.06)	2.80

Authors

Authors	Studies
Ali, S; Burnett, AK; Cahalin, P; Clark, RE; Hills, RK; Kjeldsen, L; Russell, NH; Thomas, IF	1
Aotsuka, N; Hangaishi, A; Hoshino, T; Kako, S; Kanda, Y; Kato, J; Kobayashi, T; Matsumoto, K; Mori, T; Najima, Y; Okamoto, S; Onizuka, M; Shimizu, H; Shono, K; Tachibana, T; Tanaka, M; Tsukamoto, S; Usuki, K; Watanabe, R; Yamazaki, E; Yano, S	1
Araqi Houssaini, L; Chiheb, S; Hali, F; Marnissi, F; Quessar, A	1
Baek, S; Choi, EJ; Choi, Y; Jeon, M; Jo, JC; Joo, YD; Kang, YA; Kang, YL; Kim, DY; Kim, H; Kim, SH; Ko, SH; Lee, JH; Lee, KH; Lee, YS; Lim, SN; Park, HS; Seol, M; Yun, SC	1
Chen, Y; Feng, J; Lin, F; Lu, N; Ma, Y; Shi, Y; Sun, L; Tang, L; Wang, N; Xing, C; Yu, K	1
Blaise, D; Bramanti, S; Calmels, B; Castagna, L; Chabannon, C; Charbonnier, A; Devillier, R; Faucher, C; Fürst, S; Granata, A; Harbi, S; Hospital, MA; Legrand, F; Lemarie, C; Lining, W; Maisano, V; Mokart, D; Pagliardini, T; Porta, MD; Rey, J; Saillard, C; Vey, N; Weiller, PJ	1
Barrett, J; Childs, RW; Cook, L; Donohue, T; Geller, N; Khuu, H; Kurlander, R; Leitman, S; Pantin, J; Ramos, C; Shah, AA; Stroncek, D; Tian, X; Young, NS	1
Blaise, D; Castagna, L; Chabannon, C; Crocchiolo, R; El-Cheikh, J; Faucher, C; Furst, S; Granata, A; Lemarie, C; Oudin, C; Saillard, C; Signori, A	1
Blaise, D; Bouabdallah, R; Broussais-Guillaumot, F; Calmels, B; Castagna, L; Chabannon, C; Charbonnier, A; Crocchiolo, R; Devillier, R; El-Cheikh, J; Fürst, S; Granata, A; Harbi, S; Lemarie, C; Mohty, B; Oudin, C; Rey, J; Stoppa, AM; Vey, N	1
Abedin, S; Choi, S; Couriel, DR; Levine, JE; Peres, E; Yanik, G	1
Chang, TY; Chen, SH; Hsueh, C; Hung, IJ; Jaing, TH; Yang, CP	1
Cassaday, RD; Flowers, ME; Gopal, AK; Green, DJ; Guthrie, KA; Maloney, DG; Pagel, JM; Press, OW; Rajendran, JG; Rezvani, AR; Sandmaier, BM; Sorror, ML; Storb, RF; Storer, BE	1
Choi, YS; Jeon, YW; Kim, DY; Kim, HJ; Kim, JH; Kim, YJ; Lee, JH; Lee, JW; Lee, KH; Lee, S; Lee, SE; Min, CK; Min, WS; Shin, SH; Yahng, SA; Yoon, JH	1
Aldenhoven, M; Bierings, MB; Boelens, JJ; Bonney, D; Borrill, RE; Coussons, M; Jones, SA; Mercer, J; van der Ploeg, AT; van Hasselt, PM; Versluys, B; Wijburg, FA; Wynn, RF	1
Arcese, W; Barba, P; Esquirol, A; Gayoso, J; Guidi, S; Martino, R; Montesinos, P; Moscardó, F; Parody, R; Picardi, A; Piñana, JL; Sanz, G; Sanz, J; Sanz, MA; Sierra, J; Solano, C; Terol, MJ	1
Fuji, S; Fukuda, T; Hagiwara, S; Hatanaka, K; Hidaka, M; Ito, T; Kim, SW; Kurosawa, S; Nakamae, H; Ohashi, K; Takami, A; Yamaguchi, T; Yamashita, T; Yano, S	1
Bhargava, S; Chakrabarti, A; Chakrabarti, S; Chatterjee, S; Jaiswal, SR; O'Donnell, P; Ray, K	1
Abramovici, O; Carlos Molano, L; Cuvelier, A; Darmon, A; Duval-Modeste, AB; Louvel, JP; Muir, JF; Piton, N	1
Ding, J; Jing, Y; Wang, HX; Wang, LJ; Yang, H; Yu, L; Zhu, CY	1
Hong, DS; Ji, YS; Kim, CK; Kim, HJ; Kim, KH; Kim, SH; Lee, KT; Lee, MS; Min, CW; Park, SK; Won, JH; Yun, J	1
Agovi, MA; Bacigalupo, A; Bahlis, NJ; Ballen, K; Bredeson, CN; Brown, C; Chaudhry, MA; Horowitz, MM; Kurian, S; Muehlenbien, CE; Quinlan, D; Rizzo, JD; Russell, JA; Savoie, L; Stewart, DA; Zhang, MJ	1
Cao, TM; Franke, GN; Gyurkocza, B; Hoppe, R; Lange, T; Leisenring, W; Maloney, DG; Negrin, RS; Sandmaier, BM; Shizuru, JA; Sorror, M; Storb, RF	1
Bojarska-Junak, A; Chocholska, S; Dmoszynska, A; Klimek, P; Kowal, M; Podhorecka, M	1
Chakraverty, R; Denovan, S; Fielding, AK; Hough, R; Kottaridis, PD; Linch, DC; Mackinnon, S; Mead, AJ; Mohamedbhai, S; Morris, EC; Orti, G; Peggs, KS; Thomson, KJ	1
Brewer, SC; Cleveland, KO; Gelfand, MS	1
Baron, F; Beguin, Y; Castermans, E; Cheynier, R; Dutrieux, J; Geenen, V; Gothot, A; Hannon, M; Humblet-Baron, S; Sandmaier, BM; Seidel, L; Storb, R; Vanbellinghen, JF; Willems, E	1
Ariga, T; Cho, Y; Ichikawa, M; Iguchi, A; Inamoto, J; Kaneda, M; Kawamura, N; Kobayashi, I; Kobayashi, R; Ohkura, Y; Ohshima, J; Sato, T; Takezaki, SI; Yamada, M	1
Gupta, V; Hayden, J; Ho, AY; Ireland, RM; Islam, MS; Koh, MB; Lim, Z; Marks, DI; Marsh, JC; Mufti, GJ; Pagliuca, A; Potter, V; Russell, N	1
Boudova, L; Jindra, P; Karas, M; Kazakov, D; Koza, V; Svoboda, T; Vokurka, S	1
Baxter-Lowe, LA; Cowan, MJ; Dvorak, CC; Horn, B; Law, J; Long-Boyle, JR; Musick, L	1
Bacigalupo, A; Ballerini, F; Bregante, S; Di Grazia, C; Dominietto, A; Geroldi, S; Ghiso, A; Gualandi, F; Lamparelli, T; Luchetti, S; Miglino, M; Raiola, AM; Van Lint, MT; Varaldo, R	1
Anxionnat, R; Grignon, Y; Hulin, C; Léonard, S; Taillandier, L; Vespignani, H	1
Bay, JO; Bilger, K; Blaise, D; Chabannon, C; Choufi, B; Coso, D; Faucher, C; Maraninchi, D; Mohty, M; Stoppa, AM; Tournilhac, O; Vey, N; Viens, P	1
Kami, M; Kanda, Y; Makimoto, A; Mineishi, S; Nakai, K; Saito, T; Takaue, Y; Tanosaki, R; Tobinai, K; Wakasugi, H	1
Ishii, M; Ishii, T; Kawase, I; Kimura, H; Mori, KL; Morishima, T; Ohshima, S; Saeki, Y; Yamaguchi, N	1
Bardou, VJ; Bay, JO; Bilger, K; Blaise, D; Boiron, JM; Braud, AC; Cahn, JY; Chabannon, C; Choufi, B; Faucher, C; Fleury, J; François, S; Gratecos, N; Gravis, G; Maraninchi, D; Michallet, M; Mohty, M; Sotto, JJ; Viens, P; Viret, F	1
Casper, J; Dölken, G; Freund, M; Hammer, U; Hartung, G; Kiefer, T; Kleine, HD; Knauf, W; Knopp, A; Steiner, B; Wegener, R; Wilhelm, S; Wolff, D	1
Dumontet, C; Fernández-Calotti, P; Galmarini, CM; Gamberale, R; Geffner, J; Giordano, M; Jordheim, L; Sánchez-Avalos, J	1
Beelen, D; Bornhäuser, M; Ehninger, G; Fauser, AA; Held, TK; Kiehl, M; Kröger, N; Runde, V; Schetelig, J; Schwerdtfeger, R; Siegert, W; Thiede, C; Zabelina, T; Zander, A	1
Abe, Y; Choi, I; Inaba, S; Matsushima, T; Muta, K; Nagasawa, E; Nawata, H; Nishimura, J; Ohtsuka, R; Tachikawa, Y	1
Alegre, A; Ayuk, F; Beyer, J; Brand, R; Fauser, A; Kiehl, M; Klingemann, H; Kröger, N; Leon, A; Martino, R; Myint, H; Nagler, A; Perez-Simon, JA; San Miguel, JF; Sayer, HG; Schwerdtfeger, R; Shimoni, A; Tomas, JF; Zabelina, T; Zander, AR	1
Fabbri, A; Forconi, F; Gozzetti, A; Lauria, F; Lenoci, M; Marotta, G; Raspadori, D	1
Cao, TM; Grumet, FC; Johnston, LJ; Laport, GG; Lowsky, R; Negrin, RS; Sheehan, K; Shizuru, JA; Stockerl-Goldstein, KE; Stuart, MJ; Wong, RM	1
Lennard, AL; Osborne, WL	1
Claxton, DF; Ehmann, C; Rybka, W	1
Auerbach, AD; Defor, TE; Macmillan, ML; Slungaard, A; Tan, PL; Wagner, JE	1
Austin, H; Balow, JE; Barrett, J; Childs, R; Geller, N; Igarashi, T; Lundqvist, A; Sabnis, S; Srinivasan, R; Takahashi, Y; Tisdale, J	1
Barkholt, L; Hassan, Z; Mattsson, J; Omazic, B; Remberger, M; Ringdén, O; Sairafi, D; Uzunel, M	1
Emmons, RV; Jillella, AP; Klumpp, TR; Mangan, KF; Shafer, D	1
Cho, BS; Cho, SG; Eom, KS; Kim, CC; Kim, DW; Kim, HJ; Kim, SY; Kim, YJ; Lee, JW; Lee, S; Min, CK; Min, WS	1
Grosskreutz, C; Isola, L; Osman, K; Scigliano, E	1
Bernal, MT; Besalduch, J; Brunet, MS; Caballero, D; Carrera, D; Ferra, C; Martin, J; Martino, R; Moraleda, JM; Nieto, JB; Perez-Simón, JA; Piñana, JL; Ribera, JM; Sampol, A; Sierra, J; Valcárcel, D; Vazquez, L	1
Fukuda, T; Heike, Y; Kato, R; Kim, S; Koido, K; Maruyama, D; Mori, S; Takaue, Y; Tanosaki, R; Teshima, T; Tobinai, K; Usui, E; Yamasaki, S	1
Gregory, PB; Merigan, TC; Robinson, WS	1
Bassendine, MF; Thomas, HC	1
Sherlock, S	1
Auer, IO	1
Thaler, H	1
Arnold, W; Meyer zum Büschenfelde, KH	1
Gregory, PB; Merigan, TC; Pollard, RB; Robinson, WS; Sacks, SL; Scullard, GH; Smith, JL	1
Czaja, AJ; Davis, GL	1
Merigan, TC; Smith, CI	1
Paumgartner, G	1
Carreño, V; Montaño, L; Torres, M	1
Lok, AS; Thomas, HC	1
Nicholson, KG	1
Zuckerman, AJ	1
Bassendine, MF; Chadwick, RG; Salmeron, J; Sherlock, S; Shipton, U; Thomas, HC	1
Ischida, F; Kamimura, T; Saito, S; Shibayama, T; Suzuki, S; Watanabe, S; Yoshikawa, A	1
Pelletier, G; Valla, D	1
Hino, K; Niwa, H; Sainokami, S	1
Trépo, C; Zoulim, F	1
Kim, HS; Niihara, Y; Yospur, L	1
Ballerini, F; Beltrami, G; Bruni, R; Canepa, L; Cavaliere, M; Celesti, L; Clavio, M; Congiu, M; Damasio, E; Gobbi, M; Miglino, M; Nati, S; Pierri, I; Pietrasanta, D; Rossi, E; Santini, G; Spriano, M; Vallebella, E; Vimercati, R	1
Blanche, P; Bouscary, D; Dreyfus, F; Gombert, B; Sicard, D; Stieltjes, N	1
Anderlini, P; Andersson, BS; Andreeff, M; Braunschweig, I; Bruton, J; Champlin, R; Claxton, D; Cohen, A; Davis, M; Donato, M; Gajewski, J; Giralt, S; Ippolitti, C; Khouri, I; Kornblau, S; Molldrem, J; Przepiorka, D; Thall, PF; Ueno, NT; Wang, X	1
Bornhäuser, M; Ehninger, G; Freiberg-Richter, J; Geissler, G; Helwig, A; Jenke, A; Lutterbeck, K; Oelschlagel, U; Platzbecker, U; Plettig, R; Röllig, C; Thiede, C	1
Bargay, J; Caballero, MD; Canals, C; Conde, JG; Léon, A; Martino, R; Odriozola, J; Rayón, C; San Miguel, J; Sarrá, J; Sierra, J; Simón, JA; Solano, C; Urbano-Ispízua, A	1
Buchanan, RA; Johnson, MT; Luby, JP; Mikulec, D	1
Albertini, RJ; Aronson, MD; Gump, DW; Phillips, CA; Phillips, CF	1
Dailey, MP; Ginsberg, RA; Neils, RE; Russell, TJ	1
Eddleston, AL; Williams, R	1
Hafkin, B; Merigan, TC; Pollard, RB; Robinson, WS; Tiku, ML	1
Gregory, PB; Merigan, TC; Neal, A; Pollard, RB; Robinson, WS; Smith, JL	1
Imazeki, F; Ohto, M; Omata, M; Takano, S; Yokosuka, O	1
Blayau, M; Brissot, P; David, V; Deugnier, Y; Guéguen, M; Guyader, D; Jacquelinet, C; Jouanolle, H; Lescoat, G; Messner, M	1
Suzuki, H	1
Lok, AS; Novick, DM; Thomas, HC	1
Alexander, G; Williams, R	1
Carrieri, V; Gadaleta, CD; Ventrella, F	1
Hoofnagle, JH	1
Lever, AM	1
Ouzan, D	1
Gonciarz, Z	1
Boogaerts, M; De Clerck, D; De Clercq, E; Vinckier, F	1
Arima, T; Nagashima, H; Wada, T	1
Kanazawa, H; Kinoshita, N; Shibuya, N; Yano, M	1
Hirota, K; Imazeki, F; Ito, Y; Mori, J; Okuda, K; Omata, M; Uchiumi, K; Yokosuka, O	1

Reviews

13 review(s) available for vidarabine and Chronic Disease

Article	Year
Immunological and anti-viral therapy of chronic hepatitis B virus infection. Clinics in gastroenterology, 1980, Volume: 9, Issue:1 Topics: Adjuvants, Immunologic; Antibody Formation; Antiviral Agents; Carcinoma, Hepatocellular; Chloroquine; Chronic Disease; DNA Replication; Hepatitis B; Hepatitis B virus; Humans; Immunity, Cellular; Immunization; Interferons; Liver Diseases; Liver Neoplasms; Vidarabine	1980
[New developments in therapy and prophylaxis of viral hepatitis (author's transl)]. Acta medica Austriaca, 1981, Volume: 7, Issue:2 Topics: Antiviral Agents; Chronic Disease; Hepatitis, Viral, Human; Humans; Immunization; Immunization, Passive; Immunosuppression Therapy; Immunosuppressive Agents; Interferons; Ribavirin; Vidarabine	1981
[Therapy of chronic hepatitis (author's transl)]. Leber, Magen, Darm, 1981, Volume: 11, Issue:2 Topics: Autoimmune Diseases; Azathioprine; Chloroquine; Chronic Disease; Diagnosis, Differential; Hepatitis; Hepatitis B; Hepatitis B Surface Antigens; Humans; Interferons; Levamisole; Liver Cirrhosis; Prednisone; Transfer Factor; Vidarabine; Virus Replication	1981
Current concepts in the diagnosis and management of hepatitis B surface antigen-positive chronic active hepatitis. Journal of clinical gastroenterology, 1981, Volume: 3, Issue:4 Topics: Adrenal Cortex Hormones; BCG Vaccine; Chronic Disease; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Interferons; Levamisole; Transfer Factor; Vidarabine	1981
Therapeutic approaches to chronic hepatitis B. Progress in liver diseases, 1982, Volume: 7 Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Azathioprine; Chronic Disease; Guanine; Hepatitis B; Humans; Immunoglobulins; Interferons; Levamisole; Ribavirin; Transfer Factor; Vidarabine; Vidarabine Phosphate	1982
[Therapy of liver cirrhosis]. Zeitschrift fur Gastroenterologie. Verhandlungsband, 1983, Volume: 18 Topics: Adrenal Cortex Hormones; Azathioprine; Chronic Disease; Colchicine; Hepatitis; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Cirrhosis, Biliary; Penicillamine; Propylthiouracil; Vidarabine	1983
[Treatment of chronic hepatitis B]. Revista clinica espanola, 1983, Oct-15, Volume: 171, Issue:1 Topics: Acyclovir; BCG Vaccine; Chronic Disease; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Humans; Interferons; Levamisole; Transfer Factor; Vidarabine; Vidarabine Phosphate	1983
Human viral hepatitis. Pharmacology & therapeutics, 1980, Volume: 10, Issue:1 Topics: Antiviral Agents; Carrier State; Chronic Disease; Hepatitis A; Hepatitis B; Hepatitis B virus; Hepatitis, Viral, Human; Humans; Immunity, Active; Immunity, Maternally-Acquired; Vidarabine	1980
[Medical treatment of chronic viral hepatitis]. La Revue du praticien, 1995, Jan-15, Volume: 45, Issue:2 Topics: Chronic Disease; Hepatitis, Viral, Human; Humans; Interferons; Vidarabine	1995
[Therapy of chronic hepatitis other than interferon therapy]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1994, Feb-10, Volume: 83, Issue:2 Topics: Antiviral Agents; Chronic Disease; Drugs, Chinese Herbal; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis; Humans; Interleukin-2; Prednisolone; Ribavirin; Vidarabine	1994
Nucleoside analogs in the treatment of chronic viral hepatitis. Efficiency and complications. Journal of hepatology, 1994, Volume: 21, Issue:2 Topics: Acyclovir; Chronic Disease; Hepatitis, Viral, Human; Humans; Nucleosides; Ribavirin; Vidarabine	1994
Chronic active hepatitis: immunopathogenesis and immunotherapy. Israel journal of medical sciences, 1979, Volume: 15, Issue:3 Topics: Antibodies, Viral; Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Carrier State; Chronic Disease; Clinical Trials as Topic; Cyclophosphamide; Female; Hepatitis B Surface Antigens; Hepatitis, Viral, Human; Histocompatibility Antigens; Humans; Interferons; Liver; Lymphocytes; Male; Membrane Proteins; Penicillamine; Prednisolone; Prednisone; Transfer Factor; Vidarabine	1979
Treatment of the chronic hepatitis B virus carrier state. The Journal of infection, 1988, Volume: 16, Issue:3 Topics: Arabinonucleotides; Carrier State; Chronic Disease; Hepatitis B; Humans; Immune Tolerance; Interferons; Vidarabine; Vidarabine Phosphate	1988

Trials

25 trial(s) available for vidarabine and Chronic Disease

Article	Year
A randomised comparison of FLAG-Ida versus daunorubicin combined with clofarabine in relapsed or refractory acute myeloid leukaemia: Results from the UK NCRI AML17 trial. British journal of haematology, 2022, Volume: 198, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Clofarabine; Cytarabine; Daunorubicin; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Myeloid, Acute; United Kingdom; Vidarabine	2022
Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective study. American journal of hematology, 2020, Volume: 95, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Allografts; Anemia, Aplastic; Antilymphocyte Serum; Chronic Disease; Cyclophosphamide; Disease-Free Survival; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Prospective Studies; Survival Rate; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation	2020
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2017, Volume: 23, Issue:9 Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Busulfan; Chronic Disease; Cyclophosphamide; Cyclosporine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Multiple Myeloma; Myeloablative Agonists; Prospective Studies; Recurrence; Remission Induction; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Haploidentical; Unrelated Donors; Vidarabine	2017
Unrelated Donor Peripheral Blood Stem Cell Transplantation for Patients with β-Thalassemia Major Based on a Novel Conditioning Regimen. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:8 Topics: Acute Disease; Adult; Allografts; Antilymphocyte Serum; beta-Thalassemia; Busulfan; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Infant; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Risk Factors; Survival Rate; Transplantation Conditioning; Unrelated Donors; Vidarabine	2019
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2019, Volume: 25, Issue:9 Topics: Adult; Aged; Allografts; Busulfan; Chronic Disease; Cyclophosphamide; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Stem Cell Transplantation; Survival Rate; T-Lymphocytes; Thiotepa; Transplantation Conditioning; Vidarabine	2019
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes. American journal of hematology, 2013, Volume: 88, Issue:10 Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Agents; Bone Marrow Diseases; Bone Marrow Failure Disorders; Child; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Risk Factors; Salvage Therapy; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult	2013
Double umbilical cord blood transplantation after novel myeloablative conditioning using a regimen of fludarabine, busulfan, and total lymphoid irradiation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014, Volume: 20, Issue:12 Topics: Acute Disease; Adolescent; Adult; Aged; Busulfan; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Disease-Free Survival; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hematologic Diseases; Humans; Incidence; Infant; Infant, Newborn; Male; Middle Aged; Myeloablative Agonists; Neoplasms; Pilot Projects; Survival Rate; Time Factors; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation	2014
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, CD20; Chronic Disease; Cohort Studies; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Myeloablative Agonists; Radioimmunotherapy; Survival Analysis; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation; Yttrium Radioisotopes	2015
Umbilical cord blood transplantation in adults with advanced hodgkin's disease: high incidence of post-transplant lymphoproliferative disease. European journal of haematology, 2016, Volume: 96, Issue:2 Topics: Acute Disease; Adult; Antilymphocyte Serum; Busulfan; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Female; Graft Survival; Graft vs Host Disease; Herpesvirus 4, Human; Hodgkin Disease; Humans; Infectious Mononucleosis; Male; Middle Aged; Myeloablative Agonists; Recurrence; Survival Analysis; Thiotepa; Transplantation Conditioning; Vidarabine	2016
A prospective multicenter study of unrelated bone marrow transplants using a reduced-intensity conditioning regimen with low-dose ATG-F. Bone marrow transplantation, 2016, Volume: 51, Issue:3 Topics: Adult; Aged; Allografts; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Chronic Disease; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Prospective Studies; Transplantation Conditioning; Unrelated Donors; Vidarabine	2016
Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Children with Advanced Acute Leukemia with Fludarabine-, Busulfan-, and Melphalan-Based Conditioning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2016, Volume: 22, Issue:3 Topics: Acute Disease; Adolescent; Adult; Allografts; Busulfan; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Disease-Free Survival; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Peripheral Blood Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Vidarabine	2016
Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. Blood, 2011, Aug-25, Volume: 118, Issue:8 Topics: Adolescent; Adult; Alemtuzumab; Anemia, Aplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Child; Chronic Disease; Cyclophosphamide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult	2011
Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitution. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2012, Volume: 18, Issue:11 Topics: Adolescent; Alemtuzumab; Antibodies, Monoclonal, Humanized; B-Lymphocytes; Busulfan; Child; Child, Preschool; Chronic Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Infant; Myeloablative Agonists; Neutrophils; Prospective Studies; Secondary Prevention; Severity of Illness Index; Survival Analysis; T-Lymphocytes; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult	2012
Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013, Volume: 19, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Busulfan; Chronic Disease; Cyclophosphamide; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Male; Middle Aged; Myeloablative Agonists; Retrospective Studies; Survival Rate; Thiotepa; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation	2013
Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood, 2004, Jan-15, Volume: 103, Issue:2 Topics: Acute Disease; Adult; Aged; Alkylating Agents; Busulfan; Chronic Disease; Family; Female; Histocompatibility Testing; Humans; Immunosuppressive Agents; Leukemia; Living Donors; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine	2004
Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2004, Volume: 10, Issue:10 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prognosis; Recurrence; Remission Induction; Salvage Therapy; Survival Analysis; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Vidarabine	2004
Low-dose oral fludarabine plus cyclophosphamide in elderly patients with chronic lymphoproliferative disorders. The hematology journal : the official journal of the European Haematology Association, 2004, Volume: 5, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclophosphamide; Dose-Response Relationship, Drug; Feasibility Studies; Female; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Treatment Outcome; Vidarabine	2004
The beneficial effect of chronic graft-versus-host disease on the clinical outcome of transplantation with fludarabine/busulfan-based reduced-intensity conditioning for patients with de novo myelodysplastic syndrome. International journal of hematology, 2007, Volume: 85, Issue:5 Topics: Adolescent; Adult; Antineoplastic Agents; Busulfan; Chronic Disease; Female; Follow-Up Studies; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myeloablative Agonists; Myelodysplastic Syndromes; Recurrence; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2007
Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside. The Journal of infectious diseases, 1981, Volume: 143, Issue:6 Topics: Adult; Aspartate Aminotransferases; Chronic Disease; DNA-Directed DNA Polymerase; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferons; Liver; Male; Vidarabine	1981
Adenine arabinoside therapy in HBsAg-positive chronic liver disease: a controlled study. Gastroenterology, 1981, Volume: 80, Issue:5 pt 1 Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; DNA-Directed DNA Polymerase; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Liver; Middle Aged; Vidarabine	1981
Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. Blood, 2001, Feb-01, Volume: 97, Issue:3 Topics: Acute Disease; Adenosine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cladribine; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Middle Aged; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2001
Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:8 Topics: Acute Disease; Adolescent; Adult; Aged; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Chronic Disease; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Killer Cells, Natural; Male; Middle Aged; Neoplasms; Pneumonia; Survival Analysis; Tissue Donors; Transplantation Conditioning; Treatment Outcome; Vidarabine	2001
Chronic active hepatitis: immunopathogenesis and immunotherapy. Israel journal of medical sciences, 1979, Volume: 15, Issue:3 Topics: Antibodies, Viral; Antilymphocyte Serum; Autoimmune Diseases; Azathioprine; Carrier State; Chronic Disease; Clinical Trials as Topic; Cyclophosphamide; Female; Hepatitis B Surface Antigens; Hepatitis, Viral, Human; Histocompatibility Antigens; Humans; Interferons; Liver; Lymphocytes; Male; Membrane Proteins; Penicillamine; Prednisolone; Prednisone; Transfer Factor; Vidarabine	1979
Short-term prednisolone followed by recombinant human alpha-interferon alone or combined with adenine-arabinoside in chronic hepatitis B. A prospective and randomized trial. Journal of hepatology, 1991, Volume: 12, Issue:2 Topics: Adult; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Humans; Interferon Type I; Liver Function Tests; Male; Middle Aged; Prednisolone; Prospective Studies; Recombinant Proteins; Time Factors; Vidarabine	1991
Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study. Gastroenterology, 1985, Volume: 89, Issue:2 Topics: Adult; Alanine Transaminase; Chronic Disease; DNA-Directed DNA Polymerase; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Male; Prednisolone; Prospective Studies; Vidarabine	1985

Other Studies

61 other study(ies) available for vidarabine and Chronic Disease

Article	Year
[Cutaneous complications following hematopoietic stem cell transplantation]. Bulletin du cancer, 2021, Volume: 108, Issue:9 Topics: Acute Disease; Adolescent; Adult; Allografts; Busulfan; Candidiasis; Chickenpox; Child; Chronic Disease; Dermatomycoses; Female; Graft vs Host Disease; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Herpes Genitalis; Humans; Induction Chemotherapy; Malassezia; Male; Melphalan; Middle Aged; Morocco; Prospective Studies; Skin Diseases; Skin Diseases, Infectious; Vidarabine; Young Adult	2021
National Institutes of Health classification for chronic graft-versus-host disease predicts outcome of allo-hematopoietic stem cell transplant after fludarabine-busulfan-antithymocyte globulin conditioning regimen. Leukemia & lymphoma, 2014, Volume: 55, Issue:5 Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Chemoprevention; Chronic Disease; Disease Progression; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Recurrence; Severity of Illness Index; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Young Adult	2014
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2014, Volume: 20, Issue:3 Topics: Adult; Aged; Antilymphocyte Serum; Antineoplastic Agents; Busulfan; Chronic Disease; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Prospective Studies; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine	2014
Successful hematopoietic reconstitution by unrelated donor cord blood transplantation in children with Fanconi anemia: report of 3 cases. Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:8 Topics: Animals; Antilymphocyte Serum; Antineoplastic Agents, Alkylating; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Fanconi Anemia; Graft vs Host Disease; Hematopoiesis; Histocompatibility Testing; Humans; Immunosuppressive Agents; Infant; Male; Myeloablative Agonists; Rabbits; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2014
Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:2 Topics: Acute Disease; Adult; Aged; Antilymphocyte Serum; Busulfan; Chronic Disease; Female; Graft vs Host Disease; Haplotypes; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Myeloablative Agonists; Myelodysplastic Syndromes; Recurrence; Retrospective Studies; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Transplantation, Isogeneic; Treatment Outcome; Vidarabine; Whole-Body Irradiation	2015
Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:6 Topics: Acute Disease; Busulfan; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Male; Mucopolysaccharidoses; Myeloablative Agonists; Neurodegenerative Diseases; Practice Guidelines as Topic; Prognosis; Recurrence; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Unrelated Donors; Vidarabine	2015
[Chronic alveolar condensations with erythematous cutaneous lesions]. Revue des maladies respiratoires, 2016, Volume: 33, Issue:7 Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Deoxycytidine; Diagnosis, Differential; Doxorubicin; Erythema; Female; Gemcitabine; Humans; Lung Neoplasms; Mycosis Fungoides; Pulmonary Alveoli; Skin Neoplasms; Vidarabine	2016
[Clinic Outcome of FLAG Regimen treating Patients with Refractory and Relapse Acute Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:1 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cytarabine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Middle Aged; Recurrence; Remission Induction; Survival Rate; Treatment Outcome; Vidarabine; Young Adult	2016
Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation? The Korean journal of internal medicine, 2016, Volume: 31, Issue:4 Topics: Acute Disease; Adult; Antilymphocyte Serum; Busulfan; Chronic Disease; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Kaplan-Meier Estimate; Living Donors; Male; Middle Aged; Myeloablative Agonists; Proportional Hazards Models; Recurrence; Republic of Korea; Retrospective Studies; Risk Factors; Time Factors; Transplantation Conditioning; Treatment Outcome; Vidarabine	2016
Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2008, Volume: 14, Issue:9 Topics: Acute Disease; Adolescent; Adult; Aged; Antibodies, Monoclonal; Antilymphocyte Serum; Busulfan; Chronic Disease; Cyclophosphamide; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Myeloablative Agonists; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2008
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:10 Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Child; Chronic Disease; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Living Donors; Male; Middle Aged; Myeloablative Agonists; Neoplasms; Recurrence; Retrospective Studies; Salvage Therapy; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation	2009
Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression. Acta haematologica, 2010, Volume: 123, Issue:3 Topics: ADP-ribosyl Cyclase 1; Antineoplastic Agents; Apoptosis; B-Lymphocyte Subsets; bcl-2-Associated X Protein; Biomarkers; Bone Marrow Cells; Caspase 3; Chronic Disease; Cladribine; Disease Progression; Enzyme Activation; Humans; Leukemia, Lymphoid; Membrane Glycoproteins; Prognosis; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Vidarabine; ZAP-70 Protein-Tyrosine Kinase	2010
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning. Blood, 2010, Jun-24, Volume: 115, Issue:25 Topics: Acute Disease; Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Chronic Disease; Disease-Free Survival; Female; Graft Rejection; Graft Survival; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; HLA Antigens; Humans; Incidence; Living Donors; Lymphocyte Depletion; Male; Melphalan; Middle Aged; Myeloablative Agonists; Retrospective Studies; Survival Rate; Time Factors; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2010
Rhodococcus equi pneumonia in a patient with fludarabine-treated chronic lymphocytic leukemia and CD4-lymphopenia. The American journal of the medical sciences, 2010, Volume: 340, Issue:1 Topics: Actinomycetales Infections; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; CD4 Lymphocyte Count; Chronic Disease; Female; Humans; Leukemia, Lymphoid; Lymphopenia; Opportunistic Infections; Pneumonia, Bacterial; Rhodococcus equi; Vidarabine	2010
Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age. Haematologica, 2011, Volume: 96, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Chronic Disease; Cyclophosphamide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Prognosis; Receptors, Antigen, T-Cell; Survival Rate; T-Lymphocytes; Thymus Gland; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation; Young Adult	2011
Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID. Bone marrow transplantation, 2011, Volume: 46, Issue:12 Topics: Acute Disease; Antineoplastic Agents; Child; Child, Preschool; Chronic Disease; Cord Blood Stem Cell Transplantation; Female; Fetal Blood; Graft vs Host Disease; Histocompatibility Testing; Humans; Infant; Lung Diseases, Fungal; Male; Pneumonia, Bacterial; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; X-Linked Combined Immunodeficiency Diseases	2011
Significant oral graft-versus-host disease after allogeneic stem cell transplantation with the FLU/MEL conditioning regimen. Medical science monitor : international medical journal of experimental and clinical research, 2011, Volume: 17, Issue:9 Topics: Acute Disease; Adult; Aged; Chronic Disease; Female; Graft vs Host Disease; Humans; Male; Melphalan; Middle Aged; Mouth Diseases; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult	2011
[Multifocal progressive leukoencephalitis in a patient given fludarabine for chronic lymphoid leukemia]. Revue neurologique, 2002, Volume: 158, Issue:11 Topics: Aged; Antineoplastic Agents; Biopsy; Brain; Chronic Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukoencephalopathy, Progressive Multifocal; Male; Polymerase Chain Reaction; Vidarabine	2002
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen. Blood, 2003, Jul-15, Volume: 102, Issue:2 Topics: Acute Disease; Adolescent; Adult; Antilymphocyte Serum; Busulfan; Chronic Disease; Disease Progression; Disease-Free Survival; Female; Graft vs Host Disease; Hematologic Neoplasms; Histocompatibility; Humans; Immunosuppressive Agents; Incidence; Life Tables; Lymphocyte Transfusion; Male; Middle Aged; Neoplasms; Peripheral Blood Stem Cell Transplantation; Recurrence; Risk Factors; Siblings; Survival Analysis; T-Lymphocytes; Tissue Donors; Transplantation Conditioning; Treatment Outcome; Vidarabine	2003
Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies. British journal of haematology, 2003, Volume: 121, Issue:2 Topics: Acute Disease; Adolescent; Adult; Aged; Busulfan; Chronic Disease; Cladribine; Cyclophosphamide; Disease-Free Survival; Graft vs Host Disease; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Middle Aged; Proportional Hazards Models; Recurrence; Stem Cell Transplantation; Survival Rate; Thyroglobulin; Transplantation Conditioning; Vidarabine; Whole-Body Irradiation	2003
Possibility of preventive treatment for EBV-associated NK cell-lineage proliferative disorders. Internal medicine (Tokyo, Japan), 2003, Volume: 42, Issue:3 Topics: Adolescent; Animals; Antiviral Agents; Cell Division; Chronic Disease; Culicidae; Epstein-Barr Virus Infections; Female; Foscarnet; Humans; Insect Bites and Stings; Killer Cells, Natural; Lymphoproliferative Disorders; Vidarabine; Virus Replication	2003
Reduced-intensity preparative regimen and allogeneic stem cell transplantation for advanced solid tumors. Blood, 2004, Jan-15, Volume: 103, Issue:2 Topics: Acute Disease; Adult; Antilymphocyte Serum; Bone Marrow Transplantation; Busulfan; Chronic Disease; Disease Progression; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Siblings; Stem Cell Transplantation; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine	2004
In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine. Biochemical pharmacology, 2003, Dec-01, Volume: 66, Issue:11 Topics: Aged; Aged, 80 and over; Apoptosis; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Survival; Cells, Cultured; Chronic Disease; Female; Humans; Immunosuppressive Agents; Leukemia, B-Cell; Male; Middle Aged; Statistics, Nonparametric; Vidarabine	2003
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis. Bone marrow transplantation, 2004, Volume: 33, Issue:5 Topics: Acute Disease; Adult; Aged; Antilymphocyte Serum; Busulfan; Chronic Disease; Combined Modality Therapy; Female; Follow-Up Studies; Graft vs Host Disease; Hematologic Neoplasms; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Recurrence; Retrospective Studies; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Treatment Failure; Vidarabine	2004
Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection. International journal of hematology, 2004, Volume: 79, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Combined Modality Therapy; Cyclosporine; Cytarabine; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Immunosuppressive Agents; Leukemia, Myeloid; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Pneumonia; Prednisone; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2004
Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose. Blood, 2005, Mar-15, Volume: 105, Issue:6 Topics: Adult; Aged; Antigens, CD; CD8-Positive T-Lymphocytes; Chronic Disease; Disease-Free Survival; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Granulocyte-Macrophage Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Histocompatibility Testing; Humans; Male; Middle Aged; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Recombinant Proteins; Survival Rate; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation	2005
Acute renal failure and disseminated intravascular coagulation following an idiosyncratic reaction to Alemtuzumab (Campath 1H) or fludarabine. Haematologica, 2005, Volume: 90, Issue:1 Topics: Acute Kidney Injury; Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chronic Disease; Disseminated Intravascular Coagulation; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Renal Dialysis; Transplantation Conditioning; Vidarabine	2005
Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell transplantation. British journal of haematology, 2005, Volume: 130, Issue:2 Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclophosphamide; Disease Progression; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Middle Aged; Sirolimus; Survival Analysis; Treatment Outcome; Vidarabine	2005
Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation. Pediatric blood & cancer, 2006, May-01, Volume: 46, Issue:5 Topics: Adolescent; Adult; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Fanconi Anemia; Female; Fetal Blood; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Survival Rate; T-Lymphocytes; Treatment Outcome; Vidarabine	2006
Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation. British journal of haematology, 2005, Volume: 131, Issue:1 Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclophosphamide; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2005
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning. Transplantation, 2006, Oct-15, Volume: 82, Issue:7 Topics: Acute Disease; Antifungal Agents; Cause of Death; Chronic Disease; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Mycoses; Siblings; Stem Cell Transplantation; Survival Analysis; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Failure; Treatment Outcome; Vidarabine	2006
Mixed chimerism and graft failure following conditioning with the fludarabine and cyclophosphamide nonablative regimen; conversion to full donor chimerism. American journal of hematology, 2007, Volume: 82, Issue:6 Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chimerism; Chronic Disease; Cohort Studies; Cyclophosphamide; Disease Progression; Female; Follow-Up Studies; Graft Rejection; Graft vs Host Disease; Hematologic Neoplasms; Humans; Injections, Intravenous; Lymphocyte Transfusion; Male; Middle Aged; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Tissue Donors; Transplantation Conditioning; Treatment Outcome; Vidarabine	2007
Graft versus host disease after stem cell allotransplantation with low-dose total body irradiation, fludarabine, and antithymocyte globulin. Transplantation, 2007, Sep-15, Volume: 84, Issue:5 Topics: Acute Disease; Adult; Aged; Antilymphocyte Serum; Chronic Disease; Female; Graft vs Host Disease; Humans; Male; Middle Aged; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation	2007
Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Feb-01, Volume: 26, Issue:4 Topics: Adult; Aged; Busulfan; Chronic Disease; Disease-Free Survival; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Multivariate Analysis; Myeloablative Agonists; Myelodysplastic Syndromes; Prospective Studies; Remission Induction; Survival Analysis; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2008
Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens. Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:4 Topics: Adolescent; Adult; Aged; Aspergillosis; Bacteremia; Busulfan; Catheterization, Central Venous; Chronic Disease; Communicable Diseases; Cyclophosphamide; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pneumonia, Bacterial; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation	2008
Interferon in chronic hepatitis B infection. Lancet (London, England), 1980, Feb-23, Volume: 1, Issue:8165 Topics: Chronic Disease; Drug Therapy, Combination; Hepatitis B; Humans; Interferons; Vidarabine	1980
Treatment of chronic hepatitis. Annals of the Academy of Medicine, Singapore, 1980, Volume: 9, Issue:2 Topics: Azathioprine; Chronic Disease; Hepatitis; Hepatitis B; Humans; Interferons; Levamisole; Prednisolone; Transfer Factor; Vidarabine	1980
[Therapy of chronic hepatitis (author's transl)]. Leber, Magen, Darm, 1980, Volume: 10, Issue:5 Topics: Azathioprine; Chronic Disease; Drug Therapy, Combination; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Hepatitis C; Hepatitis, Viral, Human; Humans; Immunotherapy; Interferons; Levamisole; Penicillamine; Prednisolone; Prednisone; Transfer Factor; Vidarabine	1980
Approaches to the treatment of chronic hepatitis B viral infection. Progress in clinical and biological research, 1983, Volume: 143 Topics: Acyclovir; Animals; Chronic Disease; DNA, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Humans; Interferons; Liver; Vidarabine; Virus Replication	1983
Antiviral therapy. Herpes simplex encephalitis, neonatal herpes infections, chronic hepatitis B. Lancet (London, England), 1984, Sep-29, Volume: 2, Issue:8405 Topics: Acyclovir; Antiviral Agents; Chronic Disease; Drug Therapy, Combination; Encephalitis; Female; Hepatitis B; Herpes Simplex; Humans; Infant, Newborn; Interferons; Male; Nucleic Acid Synthesis Inhibitors; Simplexvirus; Vidarabine	1984
Evaluation of the antiviral effects of adenine arabinoside on chronic HBV infection. Hepato-gastroenterology, 1982, Volume: 29, Issue:3 Topics: Adult; Chronic Disease; DNA-Directed DNA Polymerase; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Male; Middle Aged; Vidarabine	1982
Chronic lymphocytic leukemia in a patient with sickle cell anemia. The Western journal of medicine, 1998, Volume: 169, Issue:2 Topics: Anemia, Sickle Cell; Antineoplastic Agents; Chronic Disease; Fatal Outcome; Hepatitis B; Hepatitis C; Humans; Immunoglobulins; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Vidarabine	1998
First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual disease. European journal of haematology, 1998, Volume: 61, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Chronic Disease; Female; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Neoplasm, Residual; Treatment Outcome; Vidarabine	1998
Successful treatment of acquired factor VIII inhibitor with fludarabine and cyclophosphamide in chronic lymphoid leukemia. Leukemia, 1999, Volume: 13, Issue:8 Topics: Aged; Antibodies; Chronic Disease; Cyclophosphamide; Factor VIII; Female; Hemorrhage; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Vidarabine	1999
Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study. British journal of haematology, 2001, Volume: 115, Issue:3 Topics: Adolescent; Adult; Aged; Chronic Disease; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Karyotyping; Lymphoproliferative Disorders; Male; Middle Aged; Prognosis; Prospective Studies; Transplantation Conditioning; Transplantation, Homologous; Vidarabine	2001
Treatment of varicella-zoster virus infections with adenine arabinoside. The Journal of infectious diseases, 1975, Volume: 131, Issue:3 Topics: Adult; Blister; Chickenpox; Child; Chronic Disease; Encephalitis; Female; Hemoglobins; Herpes Zoster; Herpesvirus 3, Human; Humans; Lung Diseases, Obstructive; Male; Pneumonia, Viral; Recurrence; Reye Syndrome; Vidarabine; Virus Replication	1975
Vidarabine therapy for severe herpesvirus infections. An unusual syndrome of chronic varicella and transient immunologic deficiency. JAMA, 1976, Mar-29, Volume: 235, Issue:13 Topics: Adolescent; Adult; Chickenpox; Chronic Disease; Cytomegalovirus Infections; Encephalitis; Female; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Immunologic Deficiency Syndromes; Leukemia, Lymphoid; Lymphoma; Male; Middle Aged; Pneumonia, Viral; Purine Nucleosides; Skin Diseases, Infectious; Syndrome; Vidarabine	1976
Chronic herpes simplex in a patient with leukemia treated with parenteral vidarabine. Archives of dermatology, 1979, Volume: 115, Issue:12 Topics: Aged; Chronic Disease; Herpes Simplex; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Male; Vidarabine	1979
Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses. Antimicrobial agents and chemotherapy, 1979, Volume: 16, Issue:6 Topics: Acute Disease; Adult; Chronic Disease; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Surface Antigens; Humans; Immunity, Cellular; Interferons; Leukocyte Count; Lymphocytes; Male; Vidarabine	1979
Effect of vidarabine on chronic hepatitis B virus infection. JAMA, 1978, Apr-21, Volume: 239, Issue:16 Topics: Blood; Chronic Disease; DNA-Directed DNA Polymerase; Hepatitis B; Hepatitis B Antigens; Hepatitis B virus; Humans; Vidarabine; Virus Replication	1978
Effects of antiviral agents on chronic hepatitis B. Analysis using Cox proportional hazard model. Digestive diseases and sciences, 1992, Volume: 37, Issue:11 Topics: Antiviral Agents; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis, Chronic; Humans; Interferon Type I; Interferon-beta; Male; Prednisolone; Prognosis; Proportional Hazards Models; Recombinant Proteins; Vidarabine	1992
[Treatment of hepatitis B]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1990, Aug-10, Volume: 79, Issue:8 Topics: Catechin; Chronic Disease; Hepatitis B; Humans; Interferon Type I; Liver Function Tests; Prednisolone; Vidarabine	1990
Diminished responsiveness of homosexual men to antiviral therapy for HBsAg-positive chronic liver disease. Journal of hepatology, 1985, Volume: 1, Issue:1 Topics: Adult; Aspartate Aminotransferases; Carrier State; Chronic Disease; Hepatitis B; Hepatitis B Surface Antigens; Homosexuality; Humans; Immunity, Cellular; Interferon Type I; Liver Diseases; Male; Vidarabine; Vidarabine Phosphate	1985
Antiviral treatment in chronic infection with hepatitis B virus. British medical journal (Clinical research ed.), 1986, Apr-05, Volume: 292, Issue:6525 Topics: Acyclovir; Animals; Antiviral Agents; Chronic Disease; Female; Hepatitis B; Humans; Interferons; Male; Vidarabine	1986
[Therapy of chronic hepatitis]. La Clinica terapeutica, 1986, May-31, Volume: 117, Issue:4 Topics: Azathioprine; Chronic Disease; Drug Therapy, Combination; Hepatitis; Hepatitis, Chronic; Humans; Interferons; Prednisone; Vidarabine	1986
Antiviral treatment of chronic type B hepatitis. Annals of internal medicine, 1987, Volume: 107, Issue:3 Topics: Antiviral Agents; Chronic Disease; Combined Modality Therapy; Hepatitis B; Hepatitis B virus; Humans; Interferon Type I; Vidarabine; Vidarabine Phosphate; Virus Replication	1987
[What treatment of chronic hepatitis caused by the hepatitis B virus?]. Gastroenterologie clinique et biologique, 1988, Volume: 12, Issue:11 Topics: Acyclovir; Adrenal Cortex Hormones; Chronic Disease; Drug Therapy, Combination; Hepatitis B; Humans; Interferons; Vidarabine	1988
[Chronic hepatitis--problems of treatment]. Polskie Archiwum Medycyny Wewnetrznej, 1989, Volume: 82, Issue:1 Topics: Acyclovir; Azathioprine; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Hepatitis; Hepatitis, Chronic; Hepatitis, Viral, Human; Humans; Prednisone; Vidarabine	1989
Chronic herpetic infection in an immunocompromised patient: report of a case. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1987, Volume: 45, Issue:8 Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Chronic Disease; Foscarnet; Humans; Immunosuppression Therapy; Leukemia, Lymphoid; Male; Middle Aged; Phosphonoacetic Acid; Stomatitis, Herpetic; Vidarabine	1987
Natural killer activity in patients with chronic hepatitis treated with OK432, interferon, adenine arabinoside and glycyrrhizin. Gastroenterologia Japonica, 1987, Volume: 22, Issue:3 Topics: Adult; Carcinoma, Hepatocellular; Chronic Disease; Cytotoxicity, Immunologic; Female; Glycyrrhetinic Acid; Glycyrrhizic Acid; Hepatitis B; Humans; Interferon Type I; Killer Cells, Natural; Liver; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Picibanil; Radioimmunoassay; Skin Tests; Vidarabine	1987
[Three cases of Ara-A neuropathy]. Rinsho shinkeigaku = Clinical neurology, 1985, Volume: 25, Issue:1 Topics: Adult; Chronic Disease; Hepatitis B; Humans; Male; Nervous System Diseases; Vidarabine	1985